BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 709909)

  • 1. Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole.
    Rabson AR; Anderson R; Glover A
    Clin Exp Immunol; 1978 Jul; 33(1):142-9. PubMed ID: 709909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotactic function of polymorphonuclear leukocytes from patients with recurrent infections: partial correction by levamisole "in vitro".
    Stein AN; Díez RA; Sen L; Estévez ME
    Allergol Immunopathol (Madr); 1985; 13(2):127-34. PubMed ID: 4003229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil function in surgical patients: in vitro correlation of abnormal neutrophil chemotaxis by Levamisole.
    Christou NV; Meakins JL
    Surgery; 1979 May; 85(5):543-8. PubMed ID: 432816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole in chronic pyoderma.
    Papageorgiou P; Kesarwala HH; Alcid DV; Szep R; Kulkarni KN; Gocke DJ
    J Clin Lab Immunol; 1982 Jun; 8(2):121-7. PubMed ID: 7108939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic suppurative bronchopathy and motility defect of neutrophils: evaluation of an immunomodulating treatment].
    Cazzola GA; Valletta EA; Mastella G
    Pediatr Med Chir; 1989; 11(1):73-5. PubMed ID: 2717488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressed neutrophil motility in patients with recurrent herpes simplex virus infections: in vitro restoration with levamisole.
    Rabson AR; Whiting DA; Anderson R; Glover A; Koornhof HJ
    J Infect Dis; 1977 Jan; 135(1):113-6. PubMed ID: 833443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levamisole on normal and abnormal leukocyte locomotion.
    Wright DG; Kirkpatrick CH; Gallin JI
    J Clin Invest; 1977 May; 59(5):941-50. PubMed ID: 192765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils.
    Anderson R; Glover A; Koornhof HJ; Rabson AR
    J Immunol; 1976 Aug; 117(2):428-32. PubMed ID: 181491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
    Jayappa HG; Loken KI
    Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ascorbate on leucocytes: Part III. In vitro and in vivo stimulation of abnormal neutrophil motility by ascorbate.
    Anderson R; Theron A
    S Afr Med J; 1979 Sep; 56(11):429-33. PubMed ID: 550365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection, dermatitis, increased IgE, and impaired neutrophil chemotaxis. A possible relationship.
    Dahl MV; Greene WH; Quie PG
    Arch Dermatol; 1976 Oct; 112(10):1387-90. PubMed ID: 786175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation of neutrophil chemotaxis in rheumatoid arthritis using levamisole and methisoprinol.
    Mazzone A; Baigura R; Rossini S; Ricevuti G
    Clin Ther; 1986; 8(2):232-7. PubMed ID: 2421905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term therapy with sulphasalazine, levamisole, corticosteroids and ascorbic acid and of disease activity on polymorphonuclear leukocyte function in patients with ulcerative colitis.
    Hermanowicz A; Sliwiński Z; Kaczor R
    Hepatogastroenterology; 1985 Apr; 32(2):81-6. PubMed ID: 2861152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis.
    Quie PG; Cates KL
    Am J Pathol; 1977 Sep; 88(3):711-26. PubMed ID: 407800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of orally administered levamisole on random monocyte motility and chemotaxis in man.
    Nathanson SD; Zamfirescu PL; Portaro JK; deKernion JB; Fahey JL
    J Natl Cancer Inst; 1978 Aug; 61(2):301-6. PubMed ID: 355647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased chemotactic responses of neutrophils in intrinsic and mixed asthmatic patients.
    Sin B; Misirligil Z; Demirel YS; Gürbuz L; Bavbek S; Acican T
    Allergol Immunopathol (Madr); 1994; 22(5):204-8. PubMed ID: 7840021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a neutrophil chemotactic inhibitor in a patient with recurrent pyoderma.
    Robinson LD; Wooten SK; Kelly AP
    Arch Dermatol; 1979 Apr; 115(4):453-7. PubMed ID: 434868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro phagocytosis of Candida albicans by peripheral polymorphonuclear neutrophils of patients with recurrent infections:Case reports of serum-dependent abnormalities.
    Verhaegen H; de Cock W; de Cree J
    Biomedicine; 1976 Jun; 24(3):164-70. PubMed ID: 136278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro assessment of cellular and humoral immune function in pulmonary tuberculosis: correction of defective neutrophil motility by ascorbate, levamisole, metoprolol and propranolol.
    Gatner EM; Anderson R
    Clin Exp Immunol; 1980 May; 40(2):327-35. PubMed ID: 7002387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective neutrophil chemotaxis in bone marrow transplant patients.
    Clark RA; Johnson FL; Klebanoff SJ; Thomas ED
    J Clin Invest; 1976 Jul; 58(1):22-31. PubMed ID: 777029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.